BACKGROUND: Risk prediction of ventricular arrhythmias after myocardial infarction (MI) is still insufficient. Prolonged QTc is a known risk marker of mortality and ventricular arrhythmias. QTc has not achieved clinical importance in predicting arrhythmic events in patients after MI. Recent studies have displayed that the terminal part of the QT-interval, Tpeak to Tend (TpTe), may be a more promising predictor of adverse outcome. Herein, we assessed whether TpTe may serve as a predictor of ventricular arrhythmias in patients with previous MI fulfilling current implantable cardioverter-defibrillator (ICD) indications. METHODS: Seventy-six patients with previous MI eligible for ICD therapy were prospectively enrolled. ECG measurements at baseline were recorded using a 12-lead ECG with 50 mm/s paper speed. TpTe was measured from peak of the T wave to end of T wave. Events during follow up were defined as ventricular arrhythmias requiring appropriate ICD therapy, including antitachycardia pacing and shock. RESULTS: During 23 ± 19 months, arrhythmic events occurred in 36 (47%) patients. TpTe was longer in ICD patients with recorded ventricular arrhythmias compared with those without (116 ± 26 ms vs. 102 ± 20 ms; P = 0.01), whereas ejection fraction (EF) at baseline did not differ (35 ± 9% vs. 35 ± 11%; P = 0.87). TpTe was an independent predictor of ventricular arrhythmias when adjusted for age, EF and QRS duration (HR 1.16; 95% CI 1.03-1.31; P = 0.02). CONCLUSIONS: TpTe predicted malignant arrhythmias in patients after MI independently of EF. TpTe may contribute in the risk stratification of patients to identify post-MI patients disposed to malignant arrhythmias and their need of ICD therapy.
BACKGROUND: Risk prediction of ventricular arrhythmias after myocardial infarction (MI) is still insufficient. Prolonged QTc is a known risk marker of mortality and ventricular arrhythmias. QTc has not achieved clinical importance in predicting arrhythmic events in patients after MI. Recent studies have displayed that the terminal part of the QT-interval, Tpeak to Tend (TpTe), may be a more promising predictor of adverse outcome. Herein, we assessed whether TpTe may serve as a predictor of ventricular arrhythmias in patients with previous MI fulfilling current implantable cardioverter-defibrillator (ICD) indications. METHODS: Seventy-six patients with previous MI eligible for ICD therapy were prospectively enrolled. ECG measurements at baseline were recorded using a 12-lead ECG with 50 mm/s paper speed. TpTe was measured from peak of the T wave to end of T wave. Events during follow up were defined as ventricular arrhythmias requiring appropriate ICD therapy, including antitachycardia pacing and shock. RESULTS: During 23 ± 19 months, arrhythmic events occurred in 36 (47%) patients. TpTe was longer in ICDpatients with recorded ventricular arrhythmias compared with those without (116 ± 26 ms vs. 102 ± 20 ms; P = 0.01), whereas ejection fraction (EF) at baseline did not differ (35 ± 9% vs. 35 ± 11%; P = 0.87). TpTe was an independent predictor of ventricular arrhythmias when adjusted for age, EF and QRS duration (HR 1.16; 95% CI 1.03-1.31; P = 0.02). CONCLUSIONS:TpTe predicted malignant arrhythmias in patients after MI independently of EF. TpTe may contribute in the risk stratification of patients to identify post-MI patients disposed to malignant arrhythmias and their need of ICD therapy.
Authors: Dan D Matlock; Pamela N Peterson; Paul A Heidenreich; F Lee Lucas; David J Malenka; Yongfei Wang; Jeptha P Curtis; Jean S Kutner; Elliott S Fisher; Frederick A Masoudi Journal: Circ Cardiovasc Qual Outcomes Date: 2010-12-07
Authors: Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy Journal: Circulation Date: 2008-05-15 Impact factor: 29.690
Authors: M T La Rovere; G D Pinna; S H Hohnloser; F I Marcus; A Mortara; R Nohara; J T Bigger; A J Camm; P J Schwartz Journal: Circulation Date: 2001-04-24 Impact factor: 29.690
Authors: Kristina H Haugaa; Marit Kristine Smedsrud; Torkel Steen; Erik Kongsgaard; Jan Pål Loennechen; Terje Skjaerpe; Jens-Uwe Voigt; Rik Willems; Gunnar Smith; Otto A Smiseth; Jan P Amlie; Thor Edvardsen Journal: JACC Cardiovasc Imaging Date: 2010-03
Authors: Eric C Stecker; Catherine Vickers; Justin Waltz; Carmen Socoteanu; Benjamin T John; Ronald Mariani; John H McAnulty; Karen Gunson; Jonathan Jui; Sumeet S Chugh Journal: J Am Coll Cardiol Date: 2006-02-23 Impact factor: 24.094
Authors: Kemal Karaagac; Osman Can Yontar; Erhan Tenekecioglu; Fahriye Vatansever; Ozlem Arican Ozluk; Ahmet Tutuncu; Pinar Yagcioglu; Mustafa Yilmaz Journal: Int J Clin Exp Med Date: 2014-09-15
Authors: Weiding Wang; Xu Zhang; Kangyin Chen; Li Yin; Mengqi Gong; Yang Liu; Gary Tse; Lin Wu; Guangping Li; Tong Liu Journal: Ann Noninvasive Electrocardiol Date: 2019-12-17 Impact factor: 1.468
Authors: Gary Tse; Cheuk Wai Wong; Meng-Qi Gong; Lei Meng; Konstantinos P Letsas; Guang-Ping Li; Paula Whittaker; Aishwarya Bhardwaj; Abhishek C Sawant; William Kk Wu; Sunny Hei Wong; Jayaprakash Shenthar; Lap Ah Tse; Martin Cs Wong; Adrian Baranchuk; Gan-Xin Yan; Tong Liu Journal: J Geriatr Cardiol Date: 2017-12 Impact factor: 3.327